Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Ironwood Pharmaceuticals, Inc. - Class A (IRWD)

Pharmaceutical Preparations

https://www.ironwoodpharma.com

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

100 SUMMER STREET, SUITE 2300
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/03/2010

Market Cap

692,468,565

Shares Outstanding

156,130,000

Weighted SO

156,129,046

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

NBIX --.--%

AMPH --.--%

COLL --.--%

ANIP --.--%

ALKS --.--%

ITCI --.--%

DCPH --.--%

PCRX --.--%

AVDL --.--%

Beta

0.5250

Last Div

0.0000

Range

3.79-15.7

Chg

-0.1150

Avg Vol

2392279

Mkt Cap

692468565

Exch

NASDAQ

Country

US

Phone

617 621 7722

DCF Diff

-13.3438

DCF

20.3438

Div Yield

0.0000

P/S

1.7287

EV Multiple

9.3752

P/FV

-2.1426

Div Yield %

0.0000

P/E

74.8291

PEG

71.1451

Payout

0.0000

Current Ratio

3.9152

Quick Ratio

3.9152

Cash Ratio

2.3187

DSO

52.9488

DIO

0.0000

Op Cycle

52.9488

DPO

577.9465

CCC

-524.9978

Gross Margin

0.9949

Op Margin

0.3069

Pretax Margin

0.2150

Net Margin

0.0230

Eff Tax Rate

0.9166

ROA

0.0233

ROE

-0.0278

ROCE

0.3511

NI/EBT

0.1070

EBT/EBIT

0.7006

EBIT/Rev

0.3069

Debt Ratio

1.5844

D/E

-1.9482

LT Debt/Cap

2.0656

Total Debt/Cap

2.0546

Int Coverage

6.9789

CF/Debt

0.2341

Equity Multi

-1.2297

Rec Turnover

6.8935

Pay Turnover

0.6315

Inv Turnover

0.0000

FA Turnover

23.7147

Asset Turnover

1.0125

OCF/Share

0.9228

FCF/Share

0.9204

Cash/Share

0.6636

OCF/Sales

0.3663

FCF/OCF

0.9974

CF Coverage

0.2341

ST Coverage

46.4818

CapEx Coverage

380.1632

Div&CapEx Cov

380.1632

P/BV

-2.1426

P/B

-2.1426

P/S

1.7287

P/E

74.8291

P/FCF

4.7314

P/OCF

4.6975

P/CF

4.6975

PEG

71.1451

P/S

1.7287

EV Multiple

9.3752

P/FV

-2.1426

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts

Revenue Product Segmentation